Helen Marshall MBBS, MD, MPH

Professor Marshall is a medical clinician researcher with specialist training in paediatrics, vaccinology, and public health having completed a Bachelor of Medicine and Surgery, Doctorate of Medicine, Master in Public Health and Diploma in Child Health at the University of Adelaide and completed the international Advanced Vaccinology Course at the Pasteur Merieux Institute, France. She holds the position Professor in Vaccinology, School of Medicine and Deputy Director, Robinson Research Institute University of Adelaide and is the Medical Director of VIRTU, the Vaccinology and Immunology Research Trials Unit, in the Discipline of Paediatrics at the Women’s and Children’s Hospital. She has been awarded two NHMRC Career Development Fellowships in 2010 and 2015. In recognition of her research leadership she was awarded the South Australia Science Award for Excellence in Research for the Public Good in 2010, a national Public Health Association of Australia Fellowship in 2013 and a NHMRC "10 of the best" for 2016.

Professor Marshall’s research program is directed to address urgent priorities in infectious disease prevention and includes clinical trials in investigational vaccines, infectious and social epidemiology and public health. She is the lead investigator on the "B Part of It study, the largest study of its kind globally assessing the herd immunity impact of meningococcal B vaccine. Professor Marshall has received NHMRC funding for influenza and pertussis vaccine research. Her main interests include meningococcal, Human Papillomavirus and pertussis infections and their prevention by immunisation. Professor Marshall has been an investigator on over 50 paediatric, adolescent and adult clinical trials. Professor Marshall’s research group VIRTU is one of only two research centres in Australia using social science research methodologies to investigate community acceptance of immunisation programs and the only centre assessing community attitudes to introduction of new vaccines.